Skip to main content
Log in

Cancer epidemiology and patient recruitment for hadron therapy

  • Epidemiology and Socio-Economical Aspects
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

Summary

Patient recruitment is an important issue in the feasibility study of a hadron therapy programme such as Med-AUSTRON. Data on cancer incidence in Europe, Austria, and neighbouring countries are reviewed for the most frequent tumors suitable for charged particle therapy.

From these data, the numbers of potential patients suitable for MED-AUSTRON are derived for each tumor site by applying the coefficients proposed in the EULIMA-1992 feasibility study.

Whatever the assumptions made, a sufficient and adequate recruitment for MED-AUSTRON can be expected. However, an appropriate referring system has to be established within Austria and also in the neighbouring countries.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Black RJ, Bray F, Ferlay J, et al. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 1977;33:1075–1107.

    Article  Google Scholar 

  2. Chauvel P, Wambersie A (eds.). Proceedings of the EULIMA Workshop on the potential Value of Light Ion Beam Therapy, Centre Antoine-Lacassagne, Nice-France, November 3–5, 1988. Publication no EUR, 12165 EN of the Commission of the European Communities. ECSC-EEC-EAEC, Brussels-Luxembourg, and Centre Antoine-Lacassagne CAL Edition, 1989.

  3. CEC-Commission of the European Communities. Concerted Action: Cancer Treatment with Light Ions in Europe — EULIMA, Final Report. Mandrillon P (Chairman), Bewley DK (Secretary), Banti P, Battermann JJ, Chauvel P, Farley FJM, Gerard JP, Kraft G, Larsson B, Menzel HG, Meulders JP, Ryckewaert G, Sealy GRH, Vermorken AJM. Wambersie A, Wannenmacher M, CEC, rue de la Loi, 200, 1049 — Brussels, 1992.

  4. IARC-International Agency for Research on, Cancer. “Cancer Incidence in Five Continents”, volume VI. In: Parkin DM, Muir CS, Whelan SL, et al. (eds.). IARC Scientific Publications no 120, Lyon, 1992.

  5. IARC-International Agency for Research on Cancer, “Atlas of Cancer Mortality in the European Economic Community”. In: Smans M, Muir CS, Boyle P (eds.). IARC Scientific Publications no 107, Lyon, 1992.

  6. IARC-International Agency for Research on Cancer, “Trends in Cancer Incidence and Mortality”. In: Coleman MP, Esteve J, Damiecki P, et al. (eds.). IARC Scientific Publications no 121, Lyon, 1993.

  7. EC-European Commission. European Network of Cancer Registries. Luxembourg. Office of Official Publications of the European Communities, 1995.

  8. European Network of Cancer Regsitries. EUROCIM User Manual, 2nd edition, Lyon, International Agency for Research on Cancer, Lyon, 1995.

    Google Scholar 

  9. Ferlay J, Black RJ, Pisani P, et al. EUCan90: Cancer in the European Union. IARC Database no 1. International Agency for Research on Cancer, Lyon, 1996.

    Google Scholar 

  10. Österreichisches Krebsregister (Austria Cancer Registry). Krebskrankenstatistik. Wien, Österreichisches Statistisches Zentralamt, 1992.

    Google Scholar 

  11. Wambersie A, Grégoire V, Brucher JM. Potential clinical gain of proton (and heavy ion) beams for brain tumors in children. Int J Rad Oncol Biol Phys 1992;22:275–86.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Engels, H., Wambersie, A. Cancer epidemiology and patient recruitment for hadron therapy. Strahlenther Onkol 175 (Suppl 2), 95–99 (1999). https://doi.org/10.1007/BF03038902

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03038902

Key Words

Navigation